Cite
Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients.
MLA
Wadowska, Katarzyna, et al. “Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients.” Cancers, vol. 15, no. 1, Jan. 2023, p. 224. EBSCOhost, https://doi.org/10.3390/cancers15010224.
APA
Wadowska, K., Błasiak, P., Rzechonek, A., Bil-Lula, I., & Śliwińska-Mossoń, M. (2023). Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients. Cancers, 15(1), 224. https://doi.org/10.3390/cancers15010224
Chicago
Wadowska, Katarzyna, Piotr Błasiak, Adam Rzechonek, Iwona Bil-Lula, and Mariola Śliwińska-Mossoń. 2023. “Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients.” Cancers 15 (1): 224. doi:10.3390/cancers15010224.